FERRING PHARMACEUTICALS A/S: Financial statements 2013
CVR: 16313440
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
FERRING PHARMACEUTICALS A/S (CVR 16313440) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 1,102,920,000 and a net result of DKK 43,830,000. The profit margin was 4%. Equity in the 2013 report amounted to DKK 117,621,000. The solvency ratio was 39.5%. The company had 407 employees in the financial year.
- Revenue
- DKK 1,102,920,000
- Profit/Loss
- DKK 43,830,000
- Equity
- DKK 117,621,000
- Total Assets
- DKK 297,742,000
- Employees
- 407
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of December 31, 2013, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of FERRING PHARMACEUTICALS A/S.
FERRING PHARMACEUTICALS A/S has published its annual report for 2012.
About FERRING PHARMACEUTICALS A/S
FERRING PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1992. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named FERRING NORDIC PHARMACEUTICALS A/S and A/S PSE 38 NR. 1587. The management consists of Jan Peutzfeldt, Ingbritt Tolstrup Birk and Jesper Thomsen. The board consists of Marianne Kock (chair), Dag Frederik Arfst Paulsen and Jean-Frederic Paulsen. The company is owned by Ferring B.V.. The company has 522 employees (2026). In 2025, the company reported revenue of DKK 1,730,413,000 and a net result of DKK 49,005,000 compared with DKK 76,890,000 the year before. Equity in the 2025 report amounted to DKK 315,220,000.